Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Pharmaceuticals & Biotech
Create a narrative
Akums Drugs and Pharmaceuticals Community
NSEI:AKUMS Community
1
Narratives
written by author
0
Comments
on narratives written by author
11
Fair Values set
on narratives written by author
Community Investing Ideas
Akums Drugs and Pharmaceuticals
Popular
Undervalued
Overvalued
Akums Drugs and Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Global Expansion In Europe, Brazil And India Will Unlock Opportunities
Key Takeaways Expansion into regulated markets and diversified offerings position Akums for sustained top-line growth and improved earnings quality. Strategic investments and a strong balance sheet enable capacity growth, acquisitions, and leverage rising demand across key pharmaceutical segments.
View narrative
₹691.67
FV
32.0% undervalued
intrinsic discount
11.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
New
narrative
Your Valuation for
AKUMS
AKUMS
Akums Drugs and Pharmaceuticals
Your Fair Value
₹
Current Price
₹470.65
52.8% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-2b
71b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹70.9b
Earnings ₹5.9b
Advanced
Set Fair Value